Showing results (1-10 of 131) with videos related to
Sort By:
Pageof 14
Neurology|October 1, 1988
Does an inhibitory action of levodopa contribute to motor fluctuations?J G Nutt, S T Gancher, W R WoodwardClinical Pharmacology and Therapeutics|November 1, 1992
Time course of tolerance to apomorphine in parkinsonismS T Gancher, J G Nutt, W R WoodwardNeurology|June 1, 1987
Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinsonian patientsS T Gancher, J G Nutt, W R WoodwardClinical Neuropharmacology|February 1, 1996
Apomorphine tolerance in Parkinson's disease: lack of a dose effectS T Gancher, W R Woodward, J G NuttMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1995
Apomorphine infusional therapy in Parkinson's disease: clinical utility and lack of toleranceS T Gancher, J G Nutt, W R WoodwardMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Absorption of apomorphine by various routes in parkinsonismS T Gancher, J G Nutt, W R WoodwardAnnals of Neurology|June 1, 1987
3-O-methyldopa and the response to levodopa in Parkinson's diseaseJ G Nutt, W R Woodward, S T Gancher, et al.Annals of Neurology|August 1, 1989
Peripheral pharmacokinetics of apomorphine in humansS T Gancher, W R Woodward, B Boucher, et al.Clinical Neuropharmacology|October 1, 1992
Pharmacodynamics of the hypotensive effect of levodopa in parkinsonian patientsR P Irwin, J G Nutt, W R Woodward, et al.Archives of Neurology|November 1, 1992
Effect of long-term therapy on the pharmacodynamics of levodopa. Relation to on-off phenomenonJ G Nutt, W R Woodward, J H Carter, et al.Pageof 14